COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

25,676 Articles (19,427 medRxiv, 6,249 bioRxiv)

Most recent first Previous |  Page 6: Articles 51-60  | Next

Community incidence patterns drive the risk of SARS-CoV-2 outbreaks and alter intervention impacts in a high-risk institutional setting
Moore, S. M., Espana, G., Perkins, T. A., Guido, R. M., Jucaban, J. B., Hall, T. L., Huhtanen, M. E., Peel, S. A., Modjarrad, K., Hakre, S., Scott, P. T.
10.1101/2022.11.22.22282480 — Posted: 2022-11-27
Global Expansion of SARS-CoV-2 Variants of Concern: Dispersal Patterns and Influence of Air Travel
Tegally, H., Wilkinson, E., Martin, D., Moir, M., Brito, A., Giovanetti, M., Khan, K., Huber, C., Bogoch, I. I., San, J. E., Tsui, J. L.- H., Poongavanan, J., Xavier, J. S., Candido, D. d. S., Romero, F., Baxter, C., Pybus, O. G., Lessells, R., Faria, N. R., Kraemer, M. U. G., de Oliveira, T.
10.1101/2022.11.22.22282629 — Posted: 2022-11-27
Transmission prevention behaviors in US households with SARS-CoV-2 cases in 2020
Rubinstein, R. J., Mei, W., Cassidy, C. A., Streeter, G., Basham, C., Cerami, C., Lin, F.-C., Lin, J. T., Mollan, K. R.
10.1101/2022.11.25.22282730 — Posted: 2022-11-27
Prolonged T-cell activation and long COVID symptoms independently associate with severe disease at 3 months in a UK cohort of hospitalized COVID-19 patients
Santopaolo, M., Gregorova, M., Hamilton, F., Arnold, D., Long, A., Lacey, A., Oliver, E., Halliday, A., Baum, H., Hamilton, K., Milligan, R., Pearce, O., Knezevic, L., Morales Aza, B., Milne, A., Milodowski, E., Lazarus, R., Goenka, A., Finn, A., Maskell, N., Davidson, A. D., Gillespie, K., Wooldridge, L., Rivino, L.
10.1101/2022.11.25.22282759 — Posted: 2022-11-27
Point-of-care prognostication in moderate Covid-19: analytical validation and diagnostic accuracy of a soluble urokinase plasminogen activator receptor (suPAR) rapid test
Chandna, A., Mahajan, R., Gautam, P., Mwandigha, L., Dittrich, S., Kumar, V., Osborn, J., Kumar, P., Koshiaris, C., Varghese, G. M., Lubell, Y., Burza, S.
10.1101/2022.11.25.22282755 — Posted: 2022-11-27
The spatial and temporal distribution of SARS-CoV-2 from the built environment of COVID-19 patient rooms: A multicentre prospective study.
Fralick, M., Burella, M., Hinz, A., Mejbel, H. S., Guttman, D. S., Xing, L., Moggridge, J., Lapp, J., Wong, A., Nott, C., Harris-Linton, N., Kassen, R., MacFadden, D.
10.1101/2022.11.23.22282241 — Posted: 2022-11-27
How COVID-19 pandemic impacted the students and staff physical activity? A study in a Southern Brazilian University
Martins, R. C. C., Ricardo, L. I. C., Crochemore-Silva, I., Demarco, F. F., Munhoz, T. N., Levandowski, M. L., Cademartori, M. G., Schuch, H. S., Hallal, P.
10.1101/2022.11.23.22280287 — Posted: 2022-11-27
Prediction of Covid-19 vaccine effectiveness in adult populations and in clinically-vulnerable subgroups
Volkov, O., Borozdenkova, S., Gray, A.
10.1101/2022.11.22.22282637 — Posted: 2022-11-25
Substance use, psychiatric symptoms, personal mastery, and social support among COVID-19 long haulers: A compensatory model
Tam, C. C., Qiao, S., Garrett, C., Zhang, R., Aghaei, A., Aggarwal, A., Li, X.
10.1101/2022.11.23.22282679 — Posted: 2022-11-25
An FcRn-targeted mucosal vaccine against SARS-CoV-2 infection and transmission
Li, W., Wang, T., Mekhemadhom Rajendrakumar, A., Acharya, G., Miao, Z., Varghese, B. P., Yu, H., Dhakal, B., LeRoith, T., Tuo, W., Zhu, X.
10.1101/2022.11.23.517678 — Posted: 2022-11-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).